Accordingly, in a study demonstrating the efficacy of a peptide vaccine, using the melanoma specific epitope Trp2180, IFN-γ reduced the capability of CD8+ T cells to recognize and kill melanoma cells. This evidence concerns the gene CD8A and melanoma.